Authors
Wood is a urologic oncology fellow at Glickman Urological & Kidney Institute at the Cleveland Clinic in Ohio.
Rachelle Manookian, MS, LCGC, is a board-certified genetic counselor specializing in cancer genetics. She has an MS in genetic counseling from the Icahn School of Medicine at Mount Sinai, and a BS in biological sciences with a focus in neurobiology from University of California Irvine, as well as minors in Spanish literature and cognitive psychology.
Chung is a resident at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Benidir is a urologic oncology fellow at Cleveland Clinic Glickman Urological and Kidney Institute in Ohio.
Advertisement
Advertisement
Trending on Urology Times
1
Practical guide to female pelvic organ–sparing radical cystectomy
2
Targeting BCG resistance in high-risk NMIBC
3
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
4
Ridwan I. Alam, MD, MPH, discusses combining PHI and MRI to predict prostate cancer risk
5
